Browse Category

NYSE:AES News 1 October 2025

AES Corp Stock Skyrockets as BlackRock Nears $38B Takeover – What Investors Need to Know /updated: 3:00 PM EDT/

AES Corp Stock Skyrockets as BlackRock Nears $38B Takeover – What Investors Need to Know /updated: 3:00 PM EDT/

Stock Price & Recent Trading AES shares have rallied sharply in late September. As of Oct 1 the stock was around $15.3 – up over 15% on the day reuters.com. This was the largest single-day jump in nearly a year, triggered by takeover rumors. Trading volume spiked; Reuters notes AES was “boosting the S&P 500 utilities sector” as investors flocked in reuters.com. Before this move, AES had been in a year-long slump (down ~30% from last year’s high), but a minor rebound in recent weeks was dramatically accelerated by the BlackRock/GIP news. Over the last few days (Sept 28–Oct 1) the stock gyrated on deal speculation:

Stock Market Today

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

7 February 2026
Disney shares closed up 3.6% at $108.70 Friday, recovering from earlier losses as U.S. stocks rallied and the Dow topped 50,000. Investors are watching Super Bowl streaming economics and Disney’s CEO transition, with Josh D’Amaro set to take over at the March 18 meeting. Disney reported quarterly revenue of $25.98 billion and adjusted EPS of $1.63, while segment operating income fell 9% to $4.6 billion.
Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

7 February 2026
Linde plc shares fell 2.5% to $448.24 Friday after reporting Q4 sales up 6% to $8.76 billion and adjusted EPS of $4.20. The company guided 2026 adjusted EPS to $17.40–$17.90, below analyst consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets. Linde repurchased $1.4 billion in shares in Q4 and returned $7.4 billion to shareholders in 2025.
Go toTop